Title
Systems-based discovery of tomatidine as a small molecule inhibitor of skeletal muscle atrophy
DOI
10.17077/etd.2y4kh5qh
Document Type
Dissertation
Date of Degree
Spring 2015
Degree Name
PhD (Doctor of Philosophy)
Degree In
Molecular Physiology and Biophysics
First Advisor
Adams, Christopher M.
First Committee Member
Segaloff, Deborah
Second Committee Member
Moye-Rowley, Scott
Third Committee Member
Wright, Michael
Fourth Committee Member
Snyder, Peter
Fifth Committee Member
Price, David
Abstract
Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, reduced adiposity and diet-induced obesity, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.
Public Abstract
Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, reduced adiposity and diet-induced obesity, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.
Keywords
publicabstract
Pages
xi, 90 pages
Bibliography
Includes bibliographical references (pages 82-90).
Copyright
Copyright 2015 Michael Christopher Dyle
Recommended Citation
Dyle, Michael Christopher. "Systems-based discovery of tomatidine as a small molecule inhibitor of skeletal muscle atrophy." PhD (Doctor of Philosophy) thesis, University of Iowa, 2015.
https://doi.org/10.17077/etd.2y4kh5qh